Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Objectives. The aim of this study was to elucidate the frequency of major clinical manifestations in children with mitochondrial disease and establish their clinical course, prognosis, and rates of survival depending on their clinical features. Methods. We performed a retrospective review of the medical records of 400 patients who were referred for evaluation of mitochondrial disease. By use of the modified Walker criteria, only patients who were assigned a definite diagnosis were included in the study. Results. A total of 113 pediatric patients with mitochondrial disease were identified. A total of 102 (90%) patients underwent a muscle biopsy as part of the diagnostic workup. A significant respiratory chain (RC) defect, according to the diagnostic criteria, was found in 71% of the patients who were evaluated. In this cohort, complex I deficiency (32%) and combined complex I, III, and IV deficiencies (26%) were the most common causes of RC defects, followed by complex IV (19%), complex III (16%), and complex II deficiencies (7%). Pathogenic mitochondrial DNA abnormalities were found in 11.5% of the patients. A substantial fraction (40%) of patients with mitochondrial disorders exhibited cardiac disease, diagnosed by Doppler echocardiography; however, the majority (60%) of patients had predominant neuromuscular manifestations. No correlation between the type of RC defect and the clinical presentation was observed. Overall, the mean age at presentation was 40 months. However, the mean age at presentation was 33 months in the cardiac group and 44 months in the noncardiac group. Twenty-six (58%) patients in the cardiac group exhibited hypertrophic cardiomyopathy, 29% had dilated cardiomyopathy, and the remainder (13%) had left ventricular noncompaction. Patients with cardiomyopathy had an 18% survival rate at 16 years of age. Patients with neuromuscular features but no cardiomyopathy had a 95% survival at the same age. Conclusions. This study gives strong support to the view that in patients with RC defects, cardiomyopathy is more common than previously thought and tends to follow a different and more severe clinical course. Although with a greater frequency than previously reported, mitochondrial DNA mutations were found in a minority of patients, emphasizing that most mitochondrial disorders of childhood follow a Mendelian pattern of inheritance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Srere, P. A. (1969) · Methods in Enzymology · doi:10.1016/0076-6879(69)13005-0 · Cited by 2,005
Luft, R., Ikkos, D., Palmieri, G., Ernster, L., & Afzelius, B. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104637 · Cited by 981
A novel X-linked gene, G4.5. is responsible for Barth syndrome
Bione, S., D'Adamo, P., Maestrini, E., Gedeon, A. K., Bolhuis, P. A., & Toniolo, D. (1996) · Nature Genetics · doi:10.1038/ng0496-385 · Cited by 755
Pignatelli, R. H., McMahon, C. J., Dreyer, W. J., Denfield, S. W., Price, J., Belmont, J. W., Craigen, W. J., Wu, J., El Said, H., Bezold, L. I., et al. (2003) · Circulation · doi:10.1161/01.cir.0000100664.10777.b8 · Cited by 656
Self-citationDiagnostic criteria for respiratory chain disorders in adults and children
Bernier, F. P., Boneh, A., Dennett, X., Chow, C. W., Cleary, M. A., & Thorburn, D. R. (2002) · Neurology · doi:10.1212/01.wnl.0000033795.17156.00 · Cited by 574
[58] Preparation of succinate dehydrogenase and reconstitution of succinate oxidase
King, T. E. (1967) · Methods in Enzymology · doi:10.1016/0076-6879(67)10061-x · Cited by 531
Minimum birth prevalence of mitochondrial respiratory chain disorders in children
Skladal, D. (2003) · Brain · doi:10.1093/brain/awg170 · Cited by 487
Incidence of Inborn Errors of Metabolism in British Columbia, 1969–1996
Applegarth, D. A., Toone, J. R., & Lowry, R. A. R. B. (2000) · Pediatrics · doi:10.1542/peds.105.1.e10 · Cited by 407
Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy.
Ogasahara, S., Engel, A. G., Frens, D., & Mack, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2379 · Cited by 366
Darin, N., Oldfors, A., Moslemi, A., Holme, E., & Tulinius, M. (2001) · Annals of Neurology · doi:10.1002/ana.75 · Cited by 362
Cited by
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
Self-citationGorman, G. S., Chinnery, P. F., DiMauro, S., Hirano, M., Koga, Y., McFarland, R., Suomalainen, A., Thorburn, D. R., Zeviani, M., & Turnbull, D. M. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.80 · Cited by 1,563
Ackerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., Camm, A. J., Ellinor, P. T., Gollob, M., Hamilton, R., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.05.020 · Cited by 1,479
Self-citation2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Self-citationMitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
Rossignol, D. A., & Frye, R. E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2010.136 · Cited by 907
Ackerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., Camm, A. J., Ellinor, P. T., Gollob, M., Hamilton, R., et al. (2011) · Europace · doi:10.1093/europace/eur245 · Cited by 895
Self-citationGersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e230 · Cited by 818
Self-citationGenetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
Hershberger, R. E., Lindenfeld, J., Mestroni, L., Seidman, C. E., Taylor, M. R. G., & Towbin, J. A. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.01.006 · Cited by 702
Self-citationLeft ventricular non-compaction cardiomyopathy
Towbin, J. A., Lorts, A., & Jefferies, J. L. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61282-4 · Cited by 522
Self-citationMitochondrial dysfunction in autism
Giulivi, C., Zhang, Y.-F., Omanska-Klusek, A., Ross-Inta, C., Wong, S., Hertz-Picciotto, I., Tassone, F., & Pessah, I. N. (2010) · JAMA · doi:10.1001/jama.2010.1706 · Cited by 466
Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
Hershberger, R. E., Givertz, M. M., Ho, C. Y., Judge, D. P., Kantor, P. F., McBride, K. L., Morales, A., Taylor, M. R. G., Vatta, M., & Ware, S. M. (2018) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2018.03.004 · Cited by 446
Self-citationLipshultz, S. E., Law, Y. M., Asante-Korang, A., Austin, E. D., Dipchand, A. I., Everitt, M. D., Hsu, D. T., Lin, K. Y., Price, J. F., Wilkinson, J. D., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000682 · Cited by 416
The in-depth evaluation of suspected mitochondrial disease
Haas, R. H., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darin, N., Wong, L.-J., Cohen, B. H., & Naviaux, R. K. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.11.018 · Cited by 365
Self-citationSystematic identification of human mitochondrial disease genes through integrative genomics
Calvo, S., Jain, M., Xie, X., Sheth, S. A., Chang, B., Goldberger, O. A., Spinazzola, A., Zeviani, M., Carr, S. A., & Mootha, V. K. (2006) · Nature Genetics · doi:10.1038/ng1776 · Cited by 346
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.020 · Cited by 322
Self-citationMetabolism and function of mitochondrial cardiolipin
Ren, M., Phoon, C. K. L., & Schlame, M. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.04.001 · Cited by 313
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.825 · Cited by 279
Self-citationMitochondrial complex I: structure, function and pathology
Janssen, R. J. R. J., Nijtmans, L. G., Heuvel, L. P. V. D., & Smeitink, J. A. M. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0362-4 · Cited by 276
“Among the group of OXPHOS disorders, isolated complex I deficiency is the most common cause of OXPHOS dysfunction (Loeffen et al 2000; Scaglia et al 2004; Smeitink et al 2001b).”
BackgroundGötz, A., Tyynismaa, H., Euro, L., Ellonen, P., Hyötyläinen, T., Ojala, T., Hämäläinen, R. H., Tommiska, J., Raivio, T., Oresic, M., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.04.006 · Cited by 256
Genetic risk factors associated with lipid-lowering drug-induced myopathies
Vladutiu, G. D., Simmons, Z., Isackson, P. J., Tarnopolsky, M., Peltier, W. L., Barboi, A. C., Sripathi, N., Wortmann, R. L., & Phillips, P. S. (2006) · Muscle & Nerve · doi:10.1002/mus.20567 · Cited by 253
Self-citationFinsterer, J. (2009) · Pediatric Cardiology · doi:10.1007/s00246-008-9359-0 · Cited by 221
“Most frequently, LVHT is associated with mitochondrial disorders [ 117 ] hypertrophic cardiomyopathy due to MYH7, ACTC, TNNT2, or MYBPC3 mutations [93]; Barth syndrome [151]; or 1p36 deletion syndrome (Table 1 )[ 8]. About half of the patients with LVHT are children [102].”
BackgroundLeft Ventricular Noncompaction: A New Form of Heart Failure
Towbin, J. A. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2010.06.005 · Cited by 171
Self-citationPhysiological functions of peroxisome proliferator-activated receptor β
Neels, J. G., & Grimaldi, P. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00027.2013 · Cited by 161
Bioenergetics, mitochondria, and cardiac myocyte differentiation
Porter, G. A., Hom, J. R., Hoffman, D. L., Quintanilla, R. A., Bentley, K. L. D. M., & Sheu, S.-S. (2011) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2011.02.002 · Cited by 154
“Conversely, about 40% of patients identified with mitochondrial disorders exhibit hypertrophic, dilated, or non-compaction cardiomyopathy, and mouse models of mitochondrial disease have begun to examine this association (6, 7).”
BackgroundWare, S. M., El-Hassan, N., Kahler, S. G., Zhang, Q., Y-W, Miller, E., Wong, B., Spicer, R. L., Craigen, W. J., Kozel, B. A., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.063149 · Cited by 86
Self-citationClinical Use of Creatine in Neuromuscular and Neurometabolic Disorders
Tarnopolsky, M. A. (2007) · Subcellular Biochemistry · doi:10.1007/978-1-4020-6486-9_10 · Cited by 67
“Cardiomyopathy appears to be one of the more ominous signs in mitochondrial cytopathies, for its development is a negative predictive factor for survival (Scaglia et al., 2004).”
BackgroundStamerra, C. A., Di Giosia, P., Giorgini, P., Ferri, C., Sukhorukov, V. N., & Sahebkar, A. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9530007 · Cited by 48
RetractedPsychiatric disturbances in five patients with MELAS syndrome
Magner, M., Honzik, T., Tesarova, M., Dvorakova, V., Hansikova, H., Raboch, J., & Zeman, J. (2014) · Psychiatria Polska · doi:10.12740/pp/24062 · Cited by 11
Metadata
- Authors
- Scaglia, F., Towbin, J. A., Craigen, W. J., Belmont, J. W., Smith, E. O., Neish, S. R., Ware, S. M., Hunter, J. V., Fernbach, S. D., Vladutiu, G. D., Wong, L.-J. C., & Vogel, H.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2004-10-01
- Volume
- 114
- Issue
- 4
- Pages
- 925-931
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2097370116
- Cited by
- 466
- References
- 47
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.